RLS Has Entered into an Agreement To Be Acquired by Telix!Read More +

X
RLS Radiopharmacies
RLS Radiopharmacies

Making a Difference One Dose at a Time

At RLS Radiopharmacies, we harness the power of radiopharmaceuticals to deliver precise doses of radiation to targeted tissues and organs, aiding physicians in the diagnosis and treatment of potentially life-threatening conditions. As the only nationwide radiopharmacy network in the United States accredited by the Joint Commission, we set the standard for excellence in our field. Our dedicated in-house couriers and delivery fleet guarantee that your orders arrive exactly when and where they are needed. Our tailored solutions offer unparalleled flexibility.

RLS Radiopharmacies
NATIONALLY ACCREDITED NATIONALLY ACCREDITED NATIONALLY ACCREDITED

We're Transforming Healthcare

SPECT

Single photon emission computed tomography (SPECT) is the most commonly used nuclear imaging & we’re a provider of SPECT pharmaceuticals.

See Our Products

PET

Positron Emission Tomography (PET) scanning is a molecular imaging procedure & RLS offers an extensive portfolio of PET radiopharmaceuticals.

See Our Products

Therapeutics

Radiation therapy, also called radiotherapy, is a type of cancer treatment and RLS is committed to providing reliable pharmaceuticals for patient care.

See Our Products

How We Do
Nuclear Medicine

Why Choose RLS
  • Quality product
  • Reliable services
  • Flexible cancellations
  • Same-day, add-on ordering
  • 340B pricing
  • No charge for standard deliveries
  • Over 35 years in operation
  • All employee driver network

Our Locations

Our 31 radiopharmacies across 18 states are designed to leading industry specifications, led by teams of highly-experienced Nuclear Pharmacists and Radiation Safety Officers.

Stay up to date with all the latest from RLS

We Have Exciting News! RLS Radiopharmacies Has Entered into an Agreement To Be Acquired by Telix Pharmaceuticals!

We are excited to announce that RLS Radiopharmacies, America’s only Joint Commission-accredited nationwide radiopharmacy network distributing PET, SPECT, and therapeutic radiopharmaceuticals, has entered into an agreement to be acquired by Telix Pharmaceuticals Limited (ASX: TLX). Telix is a global radiopharmaceutical company focused on the development and commercialization of therapeutic and […]

September 23, 2024
Read More

Your Guide to Understanding USP General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing and Repackaging

Radiopharmaceuticals represent a unique class of drug products where compounding and other handling activities include the use of radionuclide generators, the preparation of commercially manufactured radiopharmaceutical kits, the dilution of FDA-approved multi-dose vials, the labeling of human blood products with radionuclides, the preparation of patient-specific radiopharmaceutical doses and more. These […]

April 8, 2024
Read More

RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

RLS expands rCDMO capabilities with Eckert & Ziegler’s GalliaPharm® generators for improved patient diagnostics LAKE MARY, FL & BERLIN, GERMANY – April 4, 2024 —RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacynetwork, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement […]

April 4, 2024
Read More

We Do

Nuclear Medicine